[1]钟云青,王秀峰,但晓霞,等.款冬花散对支气管扩张症痰热蕴肺证模型大鼠气道炎症的影响[J].陕西中医杂志,2022,(4):416-420.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.002]
 ZHONG Yunqing,WANG Xiufeng,DAN Xiaoxia,et al.Effect of Kuandonghua formula on airway inflammation in rats for bronchiectasis with the phlegm-heat stagnation syndrome[J].,2022,(4):416-420.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.002]
点击复制

款冬花散对支气管扩张症痰热蕴肺证模型大鼠气道炎症的影响
分享到:

《陕西中医》杂志[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年4期
页码:
416-420
栏目:
基础研究
出版日期:
2022-04-05

文章信息/Info

Title:
Effect of Kuandonghua formula on airway inflammation in rats for bronchiectasis with the phlegm-heat stagnation syndrome
作者:
钟云青1王秀峰2但晓霞1杨树栋2王 丽2
(1.广西国际壮医医院,广西 南宁 530201; 2.广西中医药大学第一附属医院,广西 南宁 530023)
Author(s):
ZHONG YunqingWANG XiufengDAN XiaoxiaYANG ShudongWANG Li
(Guangxi International Zhuang Medicine Hospital,Nanning 530201,China)
关键词:
支气管扩张症 款冬花散 痰热蕴肺证 大鼠 气道炎症 量效关系
Keywords:
Bronchiectasis Kuandonghua formula Phlegm-heat stagnation syndrome Rats Airway inflammation Quantity-effect relationship
分类号:
R 562.22
DOI:
DOI:10.3969/j.issn.1000-7369.2022.04.002
文献标志码:
A
摘要:
目的:观察款冬花散对支气管扩张症痰热蕴肺证模型大鼠气道炎症的影响。方法:70只大鼠随机分为空白组、款冬花散自身对照组、模型组、罗红霉素组、款冬花散干预组(低、中、高剂量),每组10只。采用绿脓杆菌液气管注入制备支气管扩张症动物模型。采用款冬花散干预2周后取材,观察肺组织形态改变、肺泡灌洗液(BALF)中白三烯B4(LTB4)、肿瘤坏死因子-α(TNF-α)、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)水平及肺组织LTB4、TNF-α、IL-8、IL-10 mRNA表达。结果:与空白组比较,模型组大鼠气道肺组织有大量炎性细胞浸润,BALF、肺组织的LTB4、TNF-α、IL-8、IL-10含量及mRNA表达增加(P<0.01)。款冬花散能降低气道肺组织炎症程度,减轻BALF中的LTB4、TNF-α、IL-8、IL-10水平,下调肺组织LTB4、TNF-α、IL-8、IL-10 mRNA表达,且以高剂量组较为明显(P<0.01)。结论:款冬花散在一定程度上降低支气管扩张症痰热蕴肺证模型大鼠气道炎症状态,并呈现一定的量效关系趋势。
Abstract:
Objective:To observe the effect of Kuandonghua formula on airway inflammation in rats for bronchiectasis with the phlegm-heat stagnation syndrome.Methods:A total of 70 rats were randomly divided into the blank group,the self-control group,the model group,the roxithromycin group,the Kuandonghua formula treatment group at low,middle and high dosage with 10 rats in each group.The rat model was induced by intratracheal injection of pseudomonas aeruginosa dilution.Rats in the treatment group were treated with Kuandonghua formula for 2 weeks.The morphological changes of lung tissue,concentrations in bronchoalveolar lavage fluid(BALF)and expressions of mRNA in the lung tissue including LTB4,TNF-α,IL-8 and IL-10 were evaluated.Results:Compared with the blank group,the inflammatory infiltration of lung tissue,concentrations in BALF and expressions of mRNA in the lung tissue including LTB4,TNF-α,IL-8 and IL-10 of the model group were significantly increased(P<0.01).Compared with the model group,the inflammatory infiltration of lung tissue,concentrations in BALF and expressions of mRNA in the lung tissue with regard to LTB4,TNF-α,IL-8 and IL-10 of the Kuandonghua formula treatment group were significantly decreased,which the effect of high dosage was superior to low and middle dosage(P<0.01).Conclusion:Kuandonghua formula can reduce airway inflammation in rats for bronchiectasis with the phlegm-heat stagnation syndrome,and it presents a certain quantity-effect relationship trend.

参考文献/References:

[1] Johnson C,Haworth C.Bronchiectasis[J].Medicine,2016,44(5):314-320.
[2] 周玉民,王 辰,姚婉贞,等.我国7省市城区40岁及以上居民支气管扩张症的患病情况及危险因素调查[J].中华内科杂志,2013,52(5):379-382.
[3] 成人支气管扩张症诊治专家共识编写组.成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志,2012,35(7):485-492.
[4] 陈 沁.支气管扩张中医证型的聚类分析探讨[J].中国中医急症,2010,19(9):1537-1539.
[5] 单丽囡,刘小虹.支气管扩张的中医病因病机及证治规律探讨[J].陕西中医,2005,26(4):339-340.
[6] 马明铭,李 芳,杨 慧,等.痰热清注射液对支气管扩张患者FEV1、FVC及PEF水平的影响[J].陕西中医,2019,40(10):1361-1363.
[7] 万毅刚,曹世宏,毕建军,等.大鼠支气管扩张症模型研制[J].上海实验动物科学,2000,20(2):65-68,93.
[8] 徐叔云,卞如濂,陈 修.药理实验方法学[M].3版.北京:人民卫生出版社,2002:202-204.
[9] Aliberti S,Blasi F.Bronchiectasis in 2016:Advances in our understanding[J].Lancet Respir Med,2016,4(12):940-941.
[10] 魏永梅,马俊彦,李 阳,等.纤维支气管镜肺泡灌洗治疗支气管扩张合并肺部感染临床疗效Meta分析[J].陕西医学杂志,2021,50(7):893-898.
[11] 杨 慧.阿米卡星联合纤维支气管镜肺泡灌洗术治疗支气管扩张合并铜绿假单胞菌感染临床研究[J].陕西医学杂志,2020,49(1):99-101.
[12] 郭祥君,李家树,史家欣,等.痰热清治疗支气管扩张合并铜绿假单胞菌定植和感染疗效观察[J].陕西中医,2017,38(3):287-288,291.
[13] 陈自明.妇人大全良方[M].北京:人民卫生出版社,1992:386.
[14] 吴琪珍,张朝凤,许翔鸿,等.款冬花化学成分和药理活性研究进展[J].中国野生植物资源,2015,34(2):33-36.
[15] 李 静,秦雪梅,李震宇.款冬花中倍半萜类成分的研究进展[J].中草药,2017,48(14):2964-2971.
[16] 李佳莲,方 磊,张永清,等.麻黄的化学成分和药理活性的研究进展[J].中国现代中药,2012,14(7):21-27.
[17] 张明发,沈雅琴.浙贝母药理研究进展[J].上海医药,2007,28(10):459-461.
[18] 党院霞,梁丹灵,周欣欣,等.基于分子对接技术的桑白皮总黄酮对高脂血症并高尿酸血症大鼠肾保护作用研究[J].中草药,2019,50(5):1175-1181.
[19] 景王慧,吴文进,燕 茹,等.归肺经中药桑白皮的化学、药理与药代动力学研究进展[J].世界中医药,2014,9(1):109-116.
[20] 周永学,李 敏,唐志书,等.中药石膏及其主要成分解热抗炎作用及机制研究[J].陕西中医学院学报,2012,35(5):74-76.
[21] 吴 霞,毕 赢,王一涛.前胡化学成分及药理作用的研究进展[J].食品与药品,2010,12(11):442-445.
[22] 宋芷琪,李 斌,田琨宇,等.前胡与紫花前胡的化学成分和药理作用研究进展[J].中草药,2022,53(3):948-964.
[23] 候海燕,陈 立,董俊兴.紫菀化学成分及药理活性研究进展[J].中国药学杂志,2006,41(3):161-163.
[24] 张 婷,杜冠华,陈若芸.旋覆花属植物中倍半萜类成分及生物活性的研究进展[J].中国药学杂志,2010,45(24):1889-1894.
[25] 钟云青.款冬花散治疗慢性阻塞性肺疾病急性加重期痰热郁肺证的临床观察 [J].中国中医急症,2017,26(1):149-151.
[26] 钟云青,许光兰,王秀峰,等.款冬花散治疗支气管扩张症急性加重期痰热郁肺证的临床观察[J].中国实验方剂学杂志,2018,24(20):169-174.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81760846); 博士科研启动基金资助项目(2020BS033)
更新日期/Last Update: 2022-04-08